Nelson Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Nelson Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-471	Closed	-$3K	–	268
2019 Q3	$3K	Buy	+471	New	+$3.61K	﹤0.01%	301
2019 Q2	–	Sell	-71	Closed	-$1K	–	328
2019 Q1	$1K	Hold	71	–	–	﹤0.01%	274
2018 Q4	$1K	Hold	71	–	–	﹤0.01%	280
2018 Q3	$2K	Hold	71	–	–	﹤0.01%	272
2018 Q2	$2K	Sell	71 -117	-62%	-$2.39K	﹤0.01%	246
2018 Q1	$3K	Sell	188 -300	-61%	-$5.86K	﹤0.01%	243
2017 Q4	$9K	Buy	488 +300	+160%	+$4.51K	﹤0.01%	235
2017 Q3	$3K	Hold	188	–	–	﹤0.01%	231
2017 Q2	$6K	Hold	188	–	–	﹤0.01%	230
2017 Q1	$6K	Hold	188	–	–	﹤0.01%	226
2016 Q4	$7K	Hold	188	–	–	﹤0.01%	221
2016 Q3	$9K	Hold	188	–	–	﹤0.01%	212
2016 Q2	$9K	Hold	188	–	–	﹤0.01%	213
2016 Q1	$10K	Hold	188	–	–	﹤0.01%	197
2015 Q4	$12K	Buy	188 +71	+61%	+$4.39K	﹤0.01%	191
2015 Q3	$7K	Hold	117	–	–	﹤0.01%	209
2015 Q2	$7K	Hold	117	–	–	﹤0.01%	219
2015 Q1	$7K	Buy	+117	New	+$6.8K	﹤0.01%	221

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Nelson Capital Management's TEVA Position: Q4 2019 in Review

Nelson Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2019, closing a stake of 471 shares — an estimated $3K sold.

Nelson Capital Management first reported a position in TEVA in Q1 2015 and held it in 18 quarters. The position peaked at $12K in Q4 2015. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Nelson Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2019 after selling out during the quarter.
Nelson Capital Management sold 471 Teva Pharmaceutical Industries Limited shares in Q4 2019, an estimated $3K.
Nelson Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and held it in 18 quarters.
Nelson Capital Management's Teva Pharmaceutical Industries Limited position peaked at $12K in Q4 2015.
437 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2019.

Based on Nelson Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.